22:25:18 EST Mon 09 Feb 2026
Enter Symbol
or Name
USA
CA



Cheelcare Inc
Symbol CHER
Shares Issued 19,631,337
Close 2026-02-09 C$ 1.70
Market Cap C$ 33,373,273
Recent Sedar+ Documents

ORIGINAL: Cheelcare Announces $1.0 Million Unsecured Note Financing

2026-02-09 16:51 ET - News Release

Markham, Ontario--(Newsfile Corp. - February 9, 2026) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has entered into term sheets with strategic investors for a non-brokered unsecured promissory note (the "Notes") financing for gross proceeds of up to $1,000,000 (the "Offering").

The Offering is expected to include $750,000 from Pathfinder Asset Management Ltd. ("PAML") and $250,000 from NameSilo Technologies Corp ("NameSilo" and together with PAML (the "Lenders")) subject to execution of definitive agreements and TSX Venture Exchange (the "Exchange") approval.

The Notes will have a term of eighteen (18) months and will accrue interest at the rate of 12% per annum, with principal due and payable on maturity and interest payable semi-annually. The Company has the right to redeem and prepay the Notes after one (1) year without notice, bonus or penalty.

The Company intends to use the proceeds from the Offering for working capital, inventory, product manufacturing activities, and general corporate purposes.

In connection with the Offering, the Company will issue common shares of the Company (the "Bonus Shares") to the Lenders. The number of Bonus Shares to be issued to each Lender will be equal to 20% of the principal amount of the Notes divided by the Market Price (as defined in the policies the Exchange) of $1.51 per Bonus Share, which is the closing price of the Company's common shares on February 6, 2026. An aggregate of 132,450 Bonus Shares will be issued to the Lenders. The Bonus Shares will be subject to a four month hold period commencing from the date of issuance thereof, in accordance with applicable Canadian securities laws and the policies of the Exchange.

Closing of the Offering is subject to customary closing conditions, including receipt of all necessary corporate and regulatory approvals, including Exchange approval.

No finder's fees or commissions are payable in connection with the Offering. The Lenders are arm's length parties to the Company.

About Cheelcare Inc.
Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic complex-rehab power wheelchair, Cheelcare combines engineering excellence with human-centered design to improve quality of life. For more information, please visit: www.cheelcare.ca.

For further information, please contact:
Allex Laurin, Director of Marketing
Cheelcare Inc.
Tel: 1-888-948-2680 x200
Email: alaurin@cheelcare.com

Forward-Looking Information
This news release may contain forward-looking statements. Forward-looking statements are based on current expectations and involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those expressed or implied. Such factors include, but are not limited to, general economic conditions, market demand, supply chain disruptions, and regulatory approvals. Any forward-looking statements are made as of the date of this news release, and the Company does not undertake to update any forward-looking statements except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283152

© 2026 Canjex Publishing Ltd. All rights reserved.